Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

WHN Forum background globe
AI Assistant
Forums
Forum
General Discussion,...
A common nasal spra...
 
Notifications
Clear all

A common nasal spray may block Covid infection, trial results indicate

 
General Discussion, Q&A
Last Post by Anonymous 11 months ago
1 Posts
1 Users
0 Reactions
138 Views
Solved
RSS
Posts: 1
 Dr. Anderson
Topic starter
Translate â–¼
English
Spanish
French
German
Italian
Portuguese
Russian
Chinese
Japanese
Korean
Arabic
Hindi
Dutch
Polish
Turkish
Vietnamese
Thai
Swedish
Danish
Finnish
Norwegian
Czech
Hungarian
Romanian
Greek
Hebrew
Indonesian
Malay
Ukrainian
Bulgarian
Croatian
Slovak
Slovenian
Serbian
Lithuanian
Latvian
Estonian
Sep 02, 2025 1:01 pm
(@Dr. Anderson)
Joined: 11 months ago

All participants were given Covid rapid tests twice a week over the course of nearly two months. By the end, the incidence of Covid infections in the azelastine group was 2.2%, significantly lower than the 6.7% infection rate in the placebo group.

Azelastine also appeared to reduce rates of other symptomatic respiratory infections, in general, the study published in JAMA Internal Medicine, found.

https://www.nbcnews.com/health/health-news/covid-infection-may-prevented-common-nasal-antihistamine-spray-trial-s-rcna228500


Topic Tags
azelastine nasal spray covid prevention antihistamine respiratory infections

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 50MB

 
Preview 0 Revisions Saved
Forum Jump:
  Previous Topic
Next Topic  
Related Topics
Topic Tags:  azelastine (1) , nasal spray (2) , covid prevention (1) , antihistamine (1) , respiratory infections (8) ,